INTRODUCTION
embryology, this "determination" of the stem cells is thought to be an irreversible process. Recently, it has become clear that the determined stem cell is in fact Stem cells are defined by their capacity for selfrenewal and differentiation into different cell types (87, phenotypically plastic and is able to give rise to cells from different germ layers, a process known as transdif-89,94). In the early embryonic phase, stem cells are totipotent but after a few divisions the cells are determined ferentation (10, 45, 66, 67, 71) . Because of their versatility, stem cells have gained to become specific for one of the three germ layers: the ectodermal layer, which will give rise to skin and neural ample attention over the last years for their potential in replacement/repair approaches. However, the term "stem tissue; the mesodermal layer, which will give rise to connective tissue, muscle, bone, and blood cells; and the cells" has been used loosely without clear and appropriate criteria that define the used cell types. For exam-endodermal layer, which will give rise to gastrointestinal tract and internal glandular organ cells. In the classic ple, CNS-derived neurospheres have been used exten-564 NANDOE ET AL. sively as a source for neural stem cells (NSCs), whereas ther isolate subpopulations and thus study a heterogeneous cell population that includes true stem cells as it is now clear that they are in fact heterogeneous cell populations consisting mostly of neural progenitors and well as precursor and progenitor cells. Therefore, we propose that "bone marrow stromal cells" is the proper precursors (i.e., cells that are already directed towards the neural lineage). Recently, Parker and colleagues (82) terminology for this collection of cells. We oppose that they are referred to as stem cells unless proper attempts elegantly demonstrated an overlap of 18% of stemness genes between CNS-derived neurospheres and the C17. 2 have been made to isolate a homogenous subpopulation of clonally related cells that express known "stemness" NSC clone, which fulfills the in vitro and in vivo operational definition of a stem cell (82, 98, 104) . Interestingly, genes such as Nanog, Oct-4, and Myc. Moreover, we concur with Parker and coworkers (82) that stem cells this percentage of overlap increased twofold when the C17.2 NSC clone was cultured as a neurosphere, reflect-in general are best defined operationally. Thus, the term "stem cell" can only be applied when the cells are multi-ing a shift from a "stem-like" to a "differentiated" gene expression pattern (82) . potent, able to populate a developing area or repopulate an ablated or degenerated area with appropriate cell The stroma of bone marrow houses multipotent cells that can differentiate into lineages of blood cells, stromal types, able to be serially transplanted, and able to selfrenew. For a more in-depth discussion on this opera-and skeletal tissue (24, 25, 33, 58) . It has been reported that these stem cells can also transdifferentiate into liver tional definition for stem cells we refer to a previous publication (82) . cells (84) , skeletal (29, 108) and cardiac (62,79) muscle cells, and CNS cells (6, 14, 29, 48, 53, 66, 91) , but this is HARVEST AND CULTURING OF BMSCs still debated [among others (17, 109) ]. Bone marrow is relatively easy to obtain, which circumvents the ethical Although some small variations exist, BMSCs are harvested according to largely similar protocols among concerns that surrounds the use of embryonic stem cells. Because of its availability and its reported aptitude to the many groups studying these cells for their potential in a variety of therapeutic approaches. Bone marrow transdifferentiate, stem cells from bone marrow are thought to serve as an alternative source for other types cells are usually removed from long bones such as the femurs and tibiae by flushing with cold phosphate-of stem cells that are needed for specific therapeutic approaches. buffered saline with low percentage of fetal bovine serum. These cells are washed and cultured in Dulbecco's As with stem cells in general, there is much confusion regarding the correct terminology and abilities of modified Eagle's medium or Iscove's modified Dulbecco's medium with 10-20% fetal bovine and/or horse se-cells derived from bone marrow. These cells have been referred to as "bone marrow stromal cells (BMSCs)" or rum. After 3-5 days in culture, nonadherent cells, mainly red blood cells that have a short life span of "stromal cells," because they reside in the stroma of bone marrow, or as "bone marrow stem cells" or "bone about 72 h in these culture conditions, are removed, and the remaining cells washed and further cultured in the marrow-derived stem cells," because a percentage of the cells have stem cell abilities. The cells have also been same medium. Usually within 2 weeks after initiation, the cultures consist of spindle-shaped cells with some referred to as "mesenchymal stem cells" or "bone marrow-derived mesenchymal stem cells," because of their monocytes and macrophages present (6,60). The adherent cells are removed by trypsinization and then replated origin from the mesodermal germ layer. Due to this confusing terminology it is difficult to have a clear under-for further expansion or used experimentally. These particular cells (i.e., the plastic adherent cells) are consid-standing of the true identity of the cells used in the various studies. In addition, their ability to differentiate or ered to be "the BMSCs." Generally these cells are not further phenotypically characterized. However, several transdifferentiate is unclear due mainly to the large variety of induction protocols used by different groups. For groups did analyze the presence of a battery of surface antigens and with great consistency demonstrated the example (see also below), one group reported that about 1% of human and mouse BMSCs can be induced into presence on human BMSCs of MHC class I, CD13, CD44, CD63, CD73, CD29, CD90, CD105, and CD166 the neural lineage (91), whereas another group using a different induction protocol reported that 80% of human and the absence of MHC class II, CD14, CD45, and CD34 (118) . Several other surface antigens (i.e., SH2, and rat BMSCs could become neural cells (113) . Clearly, different protocols lead to highly variable results and SH3, CD71, CD120a, and CD124) have been described for rat BMSCs (116) . this makes it difficult to fully understand the abilities of the BMSC and thus its potential for therapeutic ap-With this in mind we reviewed the literature on the use of BMSCs (harvested as described above) for repair proaches.
The majority of groups working with cells derived of the spinal cord. We will focus primarily on the application of BMSCs and not only the stem cell fraction from the stroma of bone marrow do not attempt to fur-thereof. Nevertheless, through transdifferentiation the ability of BMSCs to give rise to neural cells, it is imperative to investigate and optimize the culture conditions stem cell portion and possibly the precursors and progenitors after dedifferentiation can give rise to cells that are necessary for this transdifferentiation. Padovan and coworkers (80) demonstrated that human BMSCs from the neural lineage: neurons, astrocytes, and oligodendrocytes. Especially for smaller focal traumatic and proliferated best and expressed the highest percentage of β3-tubulin (about 27% of the total population) when demyelinating lesions it could be beneficial to acquire neural cells from BMSCs in vitro prior to transplantation cultured in the presence of 20% fetal bovine serum and 10 ng/ml basic fibroblast growth factor (bFGF or FGF-into the spinal cord or manipulate them in vivo such that they can replenish lost neural cells.
2). With fibronectin as a growth substrate this percentage was further increased to approximately 48% (80) .
DIFFERENTIATION OF BMSCs INTO BDNF or neurotrophin-3 (NT-3) elicited the expression NEURAL LINEAGE IN VITRO
of β3-tubulin up to over 40% of the cells, which could not be further increased by combining them with FGF-To get a better understanding of the true nature of BMSC-derived astrocytes, oligodendrocytes, and neu-2 (80) . With these culture conditions, the cells did not express NeuN. In the same medium but without serum, rons it is imperative to define criteria for each of them. Is it acceptable to merely assume that cells that express about 10% of the cells differentiated into GFAP-positive astrocytes (80) . Unfortunately, the authors did not fur-markers specific for a particular neural cell will also have relevant functional properties or should it be a re-ther combine these different culture conditions to possibly enhance the induction of BMSCs to differentiate into quirement to demonstrate this at least in vitro? The expression of certain molecules has been accepted as an neuronal-like cells.
Although the study of Padovan and colleagues (80) indication of differentiation into a particular neural cell type. Astrocytes express glial fibrillary acidic protein may suggest that serum is necessary for neural induction, nestin-positive neural precursor cells were found in (GFAP) and oligodendrocytes express rat insulin promoter (RIP) and myelin-basic protein (MBP). Neurons serum-free culture conditions (111) . These nestin-positive cells differentiated into GFAP-positive astrocytes are identified by the presence of βIII-tubulin (immature neurons), neuronal marker N (NeuN), neuron-specific (based on morphology; ϳ40% of the population) or NeuN-positive neuronal-like cells (ϳ19%) after 5 days enolase (NSE), neurofilaments (NF), and microtubule associated protein-2 (MAP-2). However, the expression in coculture with cerebellar granule cells (112). The groups mentioned above reported elegant and compre-of cell-specific markers alone is not adequate and, except for astrocytes, morphological characteristics that hensive studies. Unfortunately, a general consensus for culture conditions for neural induction of BMSCs has are in apparent agreement with a specific cell type can be misleading [see (56) vs. (113) ]. Indisputably, the best not yet been established. A number of studies have shown that BMSCs can be criteria for a BMSC-derived neural cell are its functional properties, which unfortunately is much easier to dem-induced to become neural-like cells in vitro by adding growth factors (2, 44, 72, 73, 80, 90, 91, 100) , dibutyryl onstrate in vitro than in vivo. Nevertheless, unless BMSC-derived cells positive for RIP or MBP myelinate cAMP (26) , or chemical agents as β-mercaptoethanol and dimethyl sulfoxide in combination with butylated central axons in vitro, their designation as oligodendrocytes should be taken with caution. Similarly, unless hydroxyanisol (11, 113, 114) . Using these various induction protocols, 2-76% of the cells became neural-like BMSC-derived cells positive for neuronal markers have appropriate electrophysiological properties their desig-cells. These results may indicate that depending on the growth factor the same intracellular pathway resulting in nation as neurons should be carefully considered. In line with this, we propose to use the additive -like for cells neural induction gets differentially activated. However, more likely is that the different growth factors exert their that express particular markers but have not been functionally characterized. We believe that this would better activity through different intracellular pathways that result in different degrees of neural induction. reflect the uncertainty of the true nature of the particular cell.
Padovan and colleagues (80) investigated whether among BMSCs there is a subpopulation that can more Several groups have reported that BMSCs can differentiate into cells that express neuronal markers or into easily differentiate into the neural lineage. They compared unsorted BMSCs and a population of BMSCs sor-cells that have a neuron-like morphology (14, 67, 68, 80, 91, 92) . Figure 1A demonstrates rat BMSCs isolated and ted on the presence of CD133 on their membrane and demonstrated that a higher percentage of the latter was cultured according to earlier described methods (6). When brain-derived neurotrophic factor (BDNF) is able to express neural markers. This phenomenon was also demonstrated by comparing gene expression pat-added to the culture, the presence of neuronal-like cells can be observed ( Fig. 1B) . To benefit most from the terns of the different subpopulations of BMSCs cells (13,58). Although this particular population of CD133-of neurons, which is approximately −70 mV. Jiang and colleagues (41,42) cultured BMSC-derived neuron-like positive cells, or cells derived thereof, were not further defined functionally, these results make it clear that the cells long term with different mitogens and cytokines, then cocultured them with fetal mouse brain astrocytes BMSC population when obtained as described above is a heterogeneous cell population. and demonstrated that the neuronal-like cells had a V rest between −8.4 and −55.4 mV. These authors also demon-Interestingly, and strongly emphasizing that more complete criteria are imperative to define BMSC-derived strated that prolonged coculture with the fetal astrocytes resulted in a further decrease of the negative resting neuronal cells, Lu and coworkers (56) demonstrated that the neuron-like cells derived from BMSCs by adding βmembrane potentials. Moreover, these cells were then able to fire action potentials (41, 42) . Regrettably, this mercaptoethanol to the culture medium (11,113,114) are actually dying cells. Time-lapse microscopy revealed study did not investigate the potential of these cells to fire trains of action potentials, a characteristic of fully that the cellular extensions protruding from the cells are merely a result of cellular shrinkage. Lu and colleagues matured neurons (16). Electrophysiologically active cells derived from (56) took this investigation one level further and demonstrated that these morphological changes of the BMSCs BMSCs were also described by Wislet-Gendebien and colleagues (112). They reported that after 4-6 days in were actually due to cellular toxicity. They showed that cells exposed to several stressors, such as detergents, culture some of the cells demonstrated sensitivity to the neurotransmitters GABA, glycine, serotonin, and gluta-chloride, and extreme pH, exhibited the same morphological characteristics (i.e., neuronal-like cells) as the mate, possessed an outward K + current but no inward Na + current, and exhibited a V rest of about −37 mV. BMSCs cultured in the presence of β-mercaptoethanol.
Clearly, neural cells obtained in vitro from BMSCs need
These characteristics correspond with those described for neurons in stage 1 of their maturation (16). Wislet-to be functionally characterized. In the case of BMSCderived neurons, demonstrating appropriate electrophys-Gendebien and colleagues (112) further showed that after 7-15 days in culture the cells were able to fire a iological behavior is crucial. single-spike action potential and had acquired V rest of ELECTROPHYSIOLOGICAL ACTIVITY −56 mV [characteristics that corresponded to neurons in OF BMSC-DERIVED NEURON-LIKE CELLS stage 2 of their maturation (16)]. These findings are exciting and demonstrate that cells within the BMSC pop-So far only a few groups published in vitro evidence that BMSC-derived neuron-like cells have electrophysi-ulation can differentiate in maturation stage 2 neurons when cultured under the appropriate conditions. It is un-ological activity appropriate for neurons (41, 42, 48, 112) . Kohyama and colleagues (48) demonstrated that such fortunate that Wislet-Gendebien and coworkers (112) could not demonstrate the presence of fully mature neu-cells exhibited a resting membrane potential (V rest ) of −20 and −50 mV at 14 and 28 days in vitro, respectively. rons [stage 3 (16)], which are able to fire trains of spikes and exhibit a normal V rest of −70 mV. The results from This was the first study that demonstrated that BMSCderived neuron-like cells acquire a V rest resembling that the studies mentioned above indicate that in vitro the BMSC-derived neuronal-like cells acquire a more nega-ery can be achieved by addressing several key areas: prevention of injury-induced cell death (neuroprotec-tive V rest in time. Perhaps they could have succeeded in creating fully matured neurons if they had cultured their tion) close and away from the injury, promoting axonal regeneration by decreasing the inhibitory nature of the cells for longer than 15 days. The differentiation of BMSCs into fully mature neurons in vitro remains one environment at the injury site or by increasing the intrinsic ability of injured neurons to grow their axon, and of the more intriguing challenges in the field of stem cells and CNS repair.
promoting myelination of regenerated axons and demyelinated intact axons. It appears that a combination of DIFFERENTIATION OF BMSCs these approaches followed by intensive rehabilitation to
INTO NEURAL LINEAGE IN VIVO
develop and stabilize new axonal circuits will be necessary. Moreover, the interventions need to be applied si-The first study that provided evidence that BMSCs can differentiate into neural-like cells in vivo was from multaneously and/or successively, thereby creating optimal conditions for morphological and functional repair. Mezey and Chandross (67) . Using a mouse model, they transplanted male bone marrow cells into the peritoneal A typical feature of the injured cord is the progressive loss of the central gray and peripheral white matter cavity of female recipients. The grafted bone marrow cell preparation did not contain neuron-or glia-like cells creating large fluid-filled cysts. To provide axons with a substrate to grow across these cavities, transplantation at the time of transplantation, although it should be noted that about 18% of the cells expressed the neural of cells has been widely explored. Many cell types, alone or in combination, have been investigated over the precursor cell marker nestin, when cultured for several weeks. Using in situ hybridization techniques, Y chro-last decades (15,88). Over the last years, the potential beneficial use of BMSCs in restorative approaches of mosome-containing neurons were located in the brain of the host, suggesting that the grafted BMSCs had crossed the spinal cord has attracted ample attention. Table 1 provides an overview of studies in which BMSCs were the blood-brain barrier and formed neurons within the CNS.
applied into the damaged spinal cord and the results that were obtained. Clearly, among these studies some re-Interestingly, Cogle and colleagues (23) also demonstrated Y chromosome-containing neurons that were sults are confusing and in disagreement with each other. For optimization of BMSC transplantation paradigms nicely integrated in the hippocampus of three female humans that had received transplants of male bone marrow for application in clinical trials several crucial questions regarding cell survival, migration, neuroprotection, axo-cells up to 6 years earlier. It should be mentioned that a fusion between a grafted BMSC and a host cell could nal regeneration, and functional recovery need to be addressed. result in false-positive results. In several studies it has been reported that BMSCs can spontaneously fuse with Cell Survival other cells in vitro (105, 117) . Whereas this is a real possibility, Cogle and coworkers (23) used fluorescence in An essential aspect for successful cell transplantation approaches is survival of the grafted cells. In vitro, situ hybridization techniques to reveal the presence of only one X chromosome, concluding that in their study BMSCs are cultured in medium containing 10-20% serum. Factors other than present in serum are not essen-the neurons could not have been the result of cell fusion. The Y chromosome-containing, transgender cells ac-tial for their survival and proliferation. In fact, addition of growth factors such as BDNF, FGF-2, or NT-3 insti-counted for approximately 1% of all neurons and 1-2% of all astrocytes and microglial cells in the hippocampus.
gates differentiation of the BMSCs into neural-like cells (80) rather than affecting survival. In vivo, in a rat con-These studies provide exciting evidence that BMSCs can migrate across the blood-brain barrier and differentiate tusion injury model, Hofstetter and colleagues (36) showed that more BMSCs survived when transplanted 1 into neural cells in the mature CNS, which is promising for the use of BMSCs in CNS reparative approaches.
week after injury compared to immediately after injury. The surviving cells were located within trabeculae that BMSCs FOR SPINAL CORD REPAIR span the injury site (22, 36) . However, with the 1-week delay only 1% of the cells (about 3000 total) survived Spinal cord injury results in cell death, axonal damage, progressive loss of tissue, and impaired motor and at 4 weeks after grafting, and although this is an increase over the percentage of cells that survived immediate sensory functions. Some restoration of function has been reported resulting from endogenous self-repair processes transplantation (<0.15%), the total number of surviving cells was very low (36). or from applied interventions. At present, due to the lack of repair approaches that cause meaningful functional It has been proposed that one of the mechanisms underlying death of cells transplanted into the spinal cord restoration, spinal cord injury results in a wheelchairbound life. In general it is thought that functional recov-is injury-induced inflammation (103). The cellular and press neural higher axon denmarkers in vivo. sity. No change in motor outcome at 3 months.
*EB-X lesion = ethylbromide injection with X-irradiation to create a demyelinating injury. †BMSCs were neurally induced following the procedure described by Woodbury et al. (114) and modified to express BDNF. molecular components of the inflammatory response 60), BDNF (20, 50, 60) , and, albeit in smaller amounts, FGF-2 (60). These factors may have pronounced effects could initiate cell death (9), which would also explain improved survival with delayed grafting paradigms. If on repair-related processes such as neuroprotection and axonal outgrowth, but they may also affect BMSC sur-this were the case, grafting into a chronically injured cord would further improve cell survival. Unfortunately, vival and/or proliferation in vivo through an autocrine action (116) . If this is the case why then do BMSCs so far there have been no conclusive results on their survival rate in the chronically injured spinal cord. In survive poorly within the injured spinal cord? It is possible that the grafted BMSCs simply do not secrete one study, BMSCs grafted into a contusion site at 3 months after injury reportedly survived an additional 4 enough of the necessary growth factors to positively effect their own survival within an extremely harsh injury weeks but actual numbers were not provided (119) . From the data so far, it has become clear that the sur-milieu with many cells and factors that negatively influence survival. Also, there may be batch-to-batch differ-vival of the BMSCs is compromised after transplantation into the injured spinal cord. ences in the ability to produce growth factors, which was demonstrated for human BMSCs (74) and that Several recent publications have reported that in vitro BMSCs produce and secrete a variety of growth factors could result in highly variable results masking the true potential of BMSCs to survive the spinal injury milieu. such as glial cell line-derived neurotrophic factor (GDNF) (31,116), nerve growth factor (NGF) (31,50, Clearly, for the development of safe and effective clinical application the survival of BMSCs after trans-are truly capable of migration within the injured spinal cord has not explicitly been answered. Future research plantation into an injury has to be improved. Especially when the cells also function to deliver factors that are should focus on these questions because the outcome is crucial for the design of BMSC transplantation para-most likely necessary to optimize the neuroprotective and axonal regeneration response. Future research digms for clinical application to repair the injured spinal cord. should concentrate on decreasing death of BMSCs within the lesion area, possibly by elevating local levels of growth factors essential for survival or by preventing Neuroprotection the upregulation of apoptotic molecules or promoting Although grafting cells into the injured spinal cord is the expression of antiapoptotic molecules.
typically applied to generate a growth response, a neuroprotective effect can also be observed (102). Repeatedly,
Cell Migration
it has been demonstrated that cellular grafts limit the Are BMSCs able to migrate towards or away from loss of nervous tissue in the injured cord (86, 102) . In the site of injury/transplantation? In vitro studies have fact, in animal models of spinal cord injury, improveshown that BMSCs express CXCR4, the receptor for the ments in motor performance seen after cell transplantachemokine CXCL12 [also known as stromal-derived tion are often contributed to neuroprotection rather than factor-1, SDF-1 (5)]. CXCL12 has been implicated in axonal regeneration. Grafting BMSCs into the contused cell migration, possibly through the extracellular signaladult spinal cord also promotes tissue sparing, which regulated kinase (ERK) and Akt phosphorylation pathwas evidenced by smaller cavities and preserved host ways (12,30). Interestingly, under some pathological white matter (3,4,77). conditions reactive astrocytes produce CXCL12 (12,69).
It is likely that the mechanism underlying the neuro-It is possible that following spinal cord damage upreguprotective effect of BMSC transplants is related to the lation of the level of CXCL12 attracts CXCR4-positive ability of the cells to produce and secrete factors that BMSCs towards the injury site. This could be the mecheither arrest and/or prevent the onset of cell-destructive anism at the basis of the homing of BMSCs into spinal events. BMSCs are known to produce and secrete GDNF cord injury sites. However, at this time it is not known (31, 116) , NGF (31, 50, 60) , BDNF (20, 50, 60) , and FGFwhether this particular chemokine is present within the 2 (60). These factors have all been implicated in neuroinjured spinal cord. protective effects. NGF and BDNF increase survival In vivo, systemically administered BMSCs have been (32, 106) and decrease apoptotic death of neurons and reported to migrate towards injury sites in the brain oligodendrocytes (97) . BDNF also increases oligoden-(51,54,59,73), but the results regarding homing towards drocyte proliferation (64) . GDNF has been implicated in the injured spinal cord have been conflicting. Recently, the rescue of motor neurons (8,21), possibly by activat- 111 In-oxine-labeled BMSCs were shown to migrate ing MAP kinase and Bcl-2, an antiapoptotic regulator poorly towards the injured spinal cord following intrave- (21) . FGF-2 is known to positively affect tissue sparing nous administration (25) . On the other hand, BMSCs (43,65) and promote neuronal survival and angiogenlabeled with iron oxide microbeads were detected using esis (65) following spinal cord injury. Another molecule magnetic resonance imaging within a spinal cord comproduced by BMSCs that could positively influence tispression injury after intravenous administration (101). sue sparing is VEGF, a potent angiogenic factor (34).
Satake and coworkers (93) demonstrated that BMSCs grafted into the lumbar subarachnoid space aggregated
Axonal Regeneration onto the cord near a thoracic contusion injury site and that a few migrated into the contusion injury. Possibly, In a few studies the axonal regeneration-promoting abilities of BMSCs have been addressed. Lu and co-the meninges may have prevented more BMSCs to migrate into the spinal cord parenchyma. Obviously, if workers (57) demonstrated that transplantation of native BMSCs into the contused spinal cord promoted modest BMSCs are able to migrate towards an injury site in the adult spinal cord, it would allow for systemic delivery sensory and motor axon regeneration, whereas grafting of neurally induced BMSCs did not result in axon of the cells, thereby avoiding invasive transplantation strategies. growth. One explanation for the failure of the neurally induced BMSCs to promote axonal regeneration in the Migration of transplanted BMSCs away from an injury site in the spinal cord might be beneficial for out-injured spinal cord is that these cells die soon after transplantation. The neural induction of the BMSCs was per-growth of regenerating axons. It was reported that such migration did not occur in a contusion injury model formed according to an earlier described method (11, 113, 114) , which, as had been already recognized by Lu (25) . However, at present, the question whether BMSCs and colleagues (56) , causes BMSCs to die rather than difficult for fore/hindlimb coordination. This affects the proper assessment of hindlimb motor performance. Other become neuron-like cells.
An alternative explanation for the lower axonal sensorimotor tests such as foot print, grid and beam walking, and analysis of gait using the CatWalk pro-growth response observed by Lu et al. (57) is that neurally induced BMSCs are less effective in eliciting such vide a more complete measurement of hindlimb function. In addition, it was unfortunate that these particular a response than undifferentiated BMSCs (for instance, because they produce and secrete less growth-promoting studies (22, 115, 119) did not investigate whether the improvements in behavior were associated with an axonal factors). At present it is known that BMSCs produce and secrete several growth factors. However, it is unknown regeneration response. Considering that in these studies the observed functional improvements appeared rela-whether neurally induced BMSCs actually produce growth factors or whether they do so but in lower tively soon after injury and transplantation, it seems that neuroprotective mechanisms (3,4,77), possibly through amounts than undifferentiated BMSCs. Indirect evidence that the neurally induced BMSCs do not produce secretion of growth factors rather than axonal regeneration responses (55) (56) (57) , were at the basis of the improve-enough growth factors to stimulate axonal regeneration was provided in two studies demonstrating that trans-ments. So far studies on behavioral effects following intras-plantation of neurally induced BMSCs genetically modified to produce and secrete BDNF did improve the pinal transplantation of BMSCs have used a variety of models in different species. In mice or rat different num-axonal growth response (57, 59) . In another study, a multifaceted and intriguing spinal cord injury/regeneration bers of BMSCs were grafted acutely into the cervical (57) or thoracic spinal cord (4,36,115), or subacutely model was used to investigate the regeneration-promoting capacity of BMSCs (55) . BMSCs modified to se- (22) or chronically (119) in the thoracic spinal cord. Most models involved a contusion injury (4,22,36,115, crete NT-3 were transplanted in a transection injury of the midthoracic dorsal columns 1 week after administra-119), others a partial transection model (57) . The survival period after transplantation as well as the studied tion of cAMP into the L4 dorsal root ganglion as a preconditioning stimulus for the sensory neurons. This was end points varied among these studies. Given the major differences between these approaches, it is difficult to then combined with injection of NT-3 after injury/grafting within and beyond the injury site (55) . The combina-compare the respective results and thus to properly value the effects of BMSCs on functional recovery and axonal tion of all interventions resulted in regeneration of ascending sensory axons into and from the BMSC graft. regeneration in the injured spinal cord so far. This brings up the question whether there should be Either cAMP or NT-3 administration alone did not result in such an axonal response. These results suggested that one particular model that should be used uniformly by groups that study the use of BMSCs in spinal cord re-a combinatorial approach that stimulates both the neural soma and axon might effectively increase the axonal re-pair. Is there a best model? We do not support the idea of only one model. In humans, the morphological and generation. Surprisingly, in the study of Lu and colleagues (55) application of cAMP alone at the level of functional outcome following spinal cord injury is highly variable. Nervous tissue loss, axonal dieback, neuronal the sensory neurons did not result in improved sensory growth, while it had been implicated in such a response death, and scar formation depend largely on factors such as the site and degree of injury and the postinjury care. earlier (75) as well as in other types of axonal regeneration responses (83) . Clearly, as with many other promis-Applying one particular model will ultimately only benefit a percentage of spinal cord injured patients. How-ing cell types for transplantation into the injured spinal cord, more extensive studies need to be performed be-ever, one particular in vivo model can be superior to another to answer a particular aspect of spinal cord in-fore BMSCs can be used effectively in repair strategies. jury and repair. For instance, neuroprotective effects of Functional Recovery BMSC transplants can best be addressed in contusion injuries, whereas their effect on axonal regeneration is It has been reported that BMSC results in significant improvement of hindlimb locomotor performance when most reliably assessed in complete transection injuries. The highly variable outcome after human spinal cord transplanted in the acutely (115) , subacutely (22) , and chronically (119) contused spinal cord. In all three stud-injury requires testing of BMSC transplantation (and of other approaches) in a variety of in vivo injury models. ies hindlimb function was evaluated using the open-field BBB test, which scores for joint movements, paw place-This would allow proper judgment as to whether following a certain injury BMSC grafting or an alternative in-ment, weight support, and fore/hindlimb coordination (7) . Although a valid way to test hindlimb function, the tervention would be best. For understanding the potential of BMSCs for spinal cord repair it would be better BBB test has limitations; the scoring is subjective and to have certain studies independently repeated to con-76), Hurler's syndrome and metachromatic leukodystrophy (47). Each of these trials has had various degrees of firm the results, which if that is the case, may establish BMSC grafting as the type of intervention best suited success depending on the measured end points. A positive outcome from all of these trials is that only one of for a particular type of injury. the 68 patients that entered in the studies mentioned has CLINICAL APPLICATION OF BMSCs suffered any side effects (i.e., mild urticaria as a reaction to the fetal bovine serum albumin in which the cells There is considerable experience with the harvesting of BMSCs from the iliac crests of patients (46) . In the were grown), indicating that BMSCs can be used safely in clinical settings. clinic, following chemotherapy and/or radiation therapy, the bone marrow microenvironment is damaged, result-There is considerable debate as to which patients with a spinal cord injury would be the ideal candidates for ing in diminished or delayed hematopoiesis (27, 63) . Allogeneic marrow transplants have been explored for re-testing cell types (including BMSCs) that have shown potential for clinical applications. Human trials ap-constitution of the damaged marrow stroma, although at present it seems that recipients of such transplants have proved by the US Food and Drug Administration (FDA) require safety data prior to efficacy data. Consequently, only host-type marrow stromal cells after transplantation (96, 99) . Also, BMSCs are more increasingly used for most cellular transplantation strategies tested in clinical trials in the US have focused on patients with function-surgical approaches for spinal fusion or for degenerated disc disease (70, 110) .
ally complete spinal cord injuries (ASIA A; American Spinal Cord Injury Association). However, for proper BMSCs have several features that make them appealing candidates for transplantation after spinal cord injury evaluation of the efficacy of transplantation strategies regarding functional improvements, patients with in-in the human, which include the facts that (a) they can be relatively easily isolated under local anesthetic (46) , complete lesions (represented by ASIA B-D) may be more beneficial. Clinical trials transplanting BMSCs (b) human BMSCs can be rapidly and extensively expanded in cell culture (6,14), (c) there is no evidence after spinal cord injury are ongoing in several countries, including Korea, Mexico, Colombia, and Brazil. Other that they produce tumors in vivo, even after immortalization to ensure an unlimited source of self-renewal ex than a Korean study (81) , results from these trials have not yet been published. In this particular study, six func-vivo (1,28), (d) they have demonstrated capacity for tissue repair (3,57), and (e) they secrete growth factors tionally complete spinal cord injured (ASIA A) patients received a BMSC transplant combined with the adminis-in vivo that can enhance regeneration/repair (19, 20) . Clearly, BMSCs may be a good candidate for transplan-tration of granulocyte macrophage-colony stimulating factor (GM-CSF). All patients were operated during the tation into the injured spinal cord. However, a concern is the considerable variation existing among donors such first 2 weeks after injury and a total of 1.8 ml with a density of 1.1 × 10 6 BMSCs/µl was injected at the epi-as gender, genetic background, and general health (74) . Therefore, we agree with Neuhuber and colleagues (74) center of a contusion lesion at 5 mm below the dorsal surface. In five out of the six patients motor and sensory that specific parameters need to be found that allow rapid and reliable selection of BMSCs with therapeutic function improved, with four of the patients switching from the ASIA A to the ASIA C level. Follow-up evalu-potential.
Based on the above-mentioned features of BMSCs, ations up to 18 months after transplantation revealed no serious complications. Although these results are very there is much excitement about the potential use of these cells for spinal cord repair. However, it is also clear that promising, detailed information concerning neurological examination is lacking. Further studies in this arena will BMSC are not the so-called "silver bullet," the one therapy that will promote regeneration and restore function need to focus on reproducibility, safety, and finally efficacy. in the injured spinal cord. In fact, it is generally accepted in the field of spinal cord injury and repair that such a CONCLUDING REMARKS "silver bullet" does not exist. Spinal cord injury is particularly complex and involves a variety of histopatho-Studies on the ability of BMSCs to transdifferentiate in vitro into the neural lineage often use different proto-logical destructive and sometimes constructive events. A treatment for spinal cord injury aimed at repair of cols [e.g., (91) vs. (113) ]. This leads to a great deal of confusion on the true capacity of these cells and thus function needs to deal with all of these events in a timely, most likely sequential, fashion. their therapeutic potential. There is a clear need for a consensus on how to induce BMSCs into the neural lin-There have already been several clinical trials that have used intravenous administration of BMSCs for spe-eage in vitro. Moreover, this procedure and in particular alternative ones that claim a higher efficiency need to cific diseases such as patients with malignancies (52), but also efficacy trials in osteogenesis imperfecta (18,37, be repeated independently. Also, there is a need for stan-cells into neuron-like cells after co-culture with hippodardized criteria [operational definition (82) ] that will campal slice. Brain Res. 1029: 114-119; 2004. result In vivo, the use of BMSCs in spinal cord injury modmarrow transplants provide tissue protection and direcels is still relatively new (see Table 1 ) and many ques- 
